These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24036073)

  • 1. Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity.
    Phalaphol A; Thueng-In K; Thanongsaksrikul J; Poungpair O; Bangphoomi K; Sookrung N; Srimanote P; Chaicumpa W
    J Virol Methods; 2013 Dec; 194(1-2):289-99. PubMed ID: 24036073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell penetrable humanized-VH/V(H)H that inhibit RNA dependent RNA polymerase (NS5B) of HCV.
    Thueng-in K; Thanongsaksrikul J; Srimanote P; Bangphoomi K; Poungpair O; Maneewatch S; Choowongkomon K; Chaicumpa W
    PLoS One; 2012; 7(11):e49254. PubMed ID: 23145135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanized-VHH transbodies that inhibit HCV protease and replication.
    Jittavisutthikul S; Thanongsaksrikul J; Thueng-In K; Chulanetra M; Srimanote P; Seesuay W; Malik AA; Chaicumpa W
    Viruses; 2015 Apr; 7(4):2030-56. PubMed ID: 25903832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HCV replication by humanized-single domain transbodies to NS4B.
    Glab-Ampai K; Malik AA; Chulanetra M; Thanongsaksrikul J; Thueng-In K; Srimanote P; Tongtawe P; Chaicumpa W
    Biochem Biophys Res Commun; 2016 Aug; 476(4):654-664. PubMed ID: 27240954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human single chain-transbodies that bound to domain-I of non-structural protein 5A (NS5A) of hepatitis C virus.
    Glab-Ampai K; Chulanetra M; Malik AA; Juntadech T; Thanongsaksrikul J; Srimanote P; Thueng-In K; Sookrung N; Tongtawe P; Chaicumpa W
    Sci Rep; 2017 Nov; 7(1):15042. PubMed ID: 29118372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase.
    Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A
    Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.
    Gal-Tanamy M; Zemel R; Bachmatov L; Jangra RK; Shapira A; Villanueva RA; Yi M; Lemon SM; Benhar I; Tur-Kaspa R
    Antiviral Res; 2010 Oct; 88(1):95-106. PubMed ID: 20705106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein.
    Chen M; Sällberg M; Sönnerborg A; Jin L; Birkett A; Peterson D; Weiland O; Milich DR
    Hepatology; 1998 Jul; 28(1):219-24. PubMed ID: 9657115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Transbodies to HCV NS3/4A Protease Inhibit Viral Replication and Restore Host Innate Immunity.
    Jittavisutthikul S; Seesuay W; Thanongsaksrikul J; Thueng-In K; Srimanote P; Werner RG; Chaicumpa W
    Front Immunol; 2016; 7():318. PubMed ID: 27617013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
    Jolivet-Reynaud C; Adida A; Michel S; Deléage G; Paranhos-Baccala G; Gonin V; Battail-Poirot N; Lacoux X; Rolland D
    J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Enzymatic Activity of an NS3 Helicase Genotype 3a Variant Sequence Obtained from a Relapse Patient.
    Provazzi PJ; Mukherjee S; Hanson AM; Nogueira ML; Carneiro BM; Frick DN; Rahal P
    PLoS One; 2015; 10(12):e0144638. PubMed ID: 26658750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolones inhibit HCV by targeting its helicase.
    Khan IA; Siddiqui S; Rehmani S; Kazmi SU; Ali SH
    Antivir Ther; 2012; 17(3):467-76. PubMed ID: 22293206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
    Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
    J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
    Liu D; Wang YS; Gesell JJ; Wyss DF
    J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase.
    Tessmann K; Erhardt A; Häussinger D; Heintges T
    J Virol Methods; 2002 May; 103(1):75-88. PubMed ID: 11906735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication.
    Stankiewicz-Drogoń A; Dörner B; Erker T; Boguszewska-Chachulska AM
    J Med Chem; 2010 Apr; 53(8):3117-26. PubMed ID: 20337460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).
    Seiwert SD; Andrews SW; Jiang Y; Serebryany V; Tan H; Kossen K; Rajagopalan PT; Misialek S; Stevens SK; Stoycheva A; Hong J; Lim SR; Qin X; Rieger R; Condroski KR; Zhang H; Do MG; Lemieux C; Hingorani GP; Hartley DP; Josey JA; Pan L; Beigelman L; Blatt LM
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4432-41. PubMed ID: 18824605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication.
    Mukherjee S; Weiner WS; Schroeder CE; Simpson DS; Hanson AM; Sweeney NL; Marvin RK; Ndjomou J; Kolli R; Isailovic D; Schoenen FJ; Frick DN
    ACS Chem Biol; 2014 Oct; 9(10):2393-403. PubMed ID: 25126694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.